TBPH: Theravance Biopharma, Inc. Company Aggregate Debts

Symbol and logo of brand Theravance Biopharma Inc (TBPH)

This Theravance Biopharma (TBPH) trading chart illustrates the dynamics of debt obligations, which currently stand at 0.07. Current financial stability is supported by regular payments from the sale of lung therapy treatments. These funds enable the execution of a plan to expand the selective compound portfolio through a partnership with Viatris. High authority among physicians confirms the company's status as a creator of innovative respiratory system solutions.

TBPH: Theravance Biopharma Company Debts 07/04/2022 - 10/10/2026

Theravance Biopharma, Inc. (TBPH) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Price Performance Chart Theravance Corp|TBPH - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Theravance|TBPH - Total Company Value
- balance sheet equity data:
Accounting Value of a Share Theravance Biopharma|TBPH - Company Book Value|Market Cap to Net Assets Ratio theravance.com|TBPH - Company Total Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Theravance Biopharma|TBPH - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Theravance Biopharma Inc|TBPH - Company Debts|Debts to Book Value Theravance|TBPH - Company Long-Term Liabilities|Amount of Current Liabilities Theravance Biopharma|Intermediate Coverage Ratio theravance.com
- earnings and valuation multiples information:
TBPH - Net Profit
Fundamental company analysis:TBPH - Theravance Corp
Signature product of Theravance Biopharma Inc

Minimizing fundamental risks requires strict monitoring of the issuer's debt load. This indicator aggregates total borrowed capital, allowing for the tracking of liability dynamics without reporting time lags. For Theravance Biopharma (TBPH), with its inelastic demand for COPD therapy, moderate leverage optimizes growth. The stability of the liability curve in the company's history confirms effective loan management. The absence of sharp spikes indicates financial stability.

Who Theravance Biopharma competes with

HLN (Haleon Corp) - Aggregate Debt Obligations|Company Aggregate Debts KVUE (Kenvue Inc.)|Company Aggregate Debts veronapharma.com VRNA|MENS - Company Debts|Aggregate Debt Obligations LGND (Ligand Pharmaceuticals Incorporated)|Amneal Pharmaceuticals Inc (AMRX) - Company Debts|Company Total Debt Perrigo Corp|ALVO (Alvotech) - Company Aggregate Debts|Company Aggregate Debts liquidia.com|Company Total Debt GLPG (Galapagos)|ANIP (ANI Pharmaceuticals Inc) - Aggregate Debt Obligations|Company Debts MannKind Corp. MNKD|Amphastar Corp (AMPH) - Company Cumulative Debt|PCRX: Company Total Debt|ars-pharma.com - Company Cumulative Indebtedness|AQST: Company Aggregate Debts|scPharmaceuticals - Aggregate Debt Obligations|TECX (Tectonic Therapeutic Inc.) - Company Aggregate Debts|Company Cumulative Debt Tonix Pharmaceuticals Holding TNXP|Company Debts China SXT Pharmaceuticals (SXTC)|EPRX (eupraxiapharma.com) - Aggregate Debt Obligations|BioHarvest Sciences Inc. - Company Total Debt|Company Cumulative Indebtedness EXOZ (Invizyne Technologies)|Oramed Pharma - Company Aggregate Debts|Aggregate Debt Obligations ENTX (Entera Bio Ltd.)|HYFT: Company Aggregate Debts|Company Cumulative Debt abvcpharma.com (ABVC)|Company Debts Cumberland Pharmaceuticals Inc.|QNTM: Aggregate Debt Obligations|Company Aggregate Debts FGEN|Company Aggregate Debts Telomir Pharmaceuticals Corp (TELO)|Rani Therapeutics Holdings, Inc. - Company Total Debt|Synergy CHC Corp. - Company Debts|Rallybio Corp. - Company Aggregate Debts|LEXX - Company Aggregate Debts|Pulmatrix Corp (PULM) - Company Debts|Company Aggregate Debt PTHL|APM (Aptorum Group Ltd) - Company Aggregate Debts|Company Total Debt lyratherapeutics.com (LYRA)|Company Aggregate Debts IBO|TNFA - Company Cumulative Debt|cbdMD - Company Total Debt|Aggregate Debt Obligations PRFX|Auris Medical - Company Aggregate Debts|LIPO: Company Debts|OPTN: Company Aggregate Debts|PIRS - Company Total Debt Obligations|Company Debts Procaps Group SA|Company Cumulative Debt Petros Pharma PTPI|Company Debts Qilian International (QLI)|SLRN: Company Aggregate Indebtedness|Company Aggregate Debts TFFP (TFF Pharmaceuticals, Inc.)